Archive for August, 2013

New DOD Disclosure of Information Clause

Or perhaps we should say NON-Disclosure PART 252—SOLICITATION PROVISIONS AND CONTRACT CLAUSES 1.The authority citation for part 252 continue to read as follows: Authority: 41 U.S.C. 1303 and 48 CFR Chapter 1. 2.Revise section 252.204-7000 to read...

Read More

Engineered in India — Patent Law 2.0

NEJM http://www.nejm.org/doi/full/10.1056/NEJMp1304400?query=TOC Amy Kapczynski, J.D. N Engl J Med 2013; 369:497-499August 8, 2013DOI: 10.1056/NEJMp1304400 “India is known as the “pharmacy of the developing world,” because it supplies much of the world’s demand for affordable, generic...

Read More

On Access and Accountability — Two Supreme Court Rulings on Generic Drugs

NEJM http://www.nejm.org/doi/full/10.1056/NEJMp1308368?query=TOC Marcia M. Boumil, J.D., LL.M., and Gregory D. Curfman, M.D. August 7, 2013DOI: 10.1056/NEJMp1308368 “In June, the U.S. Supreme Court issued two rulings regarding the marketing of generic drugs that may alter the...

Read More